| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1066 |
| Trial ID | ChiCTR-ONh-17012060 |
| Disease | B-Cell Acute Lymphoblastic Leukemia/Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | PZ01 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical investigation of anti-CD19 Chimeric Antigen Receptor T Cells (PZ01) for relapsed/ refractory B-cell Acute Lymphoblastic Leukemia/B cell Lymphoma |
| Year | 2017 |
| Country | China |
| Company sponsor | Navy General Hospita |
| Cohort 1 | |||||||
|
|||||||